ASX:GSS

Genetic Signatures Competitors

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

VolumeN/A

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Genetic Signatures (ASX:GSS) Vs. BUX, IME, BD1, CRL, CTE, and DVL

Should you be buying GSS stock or one of its competitors? Companies in the industry of "diagnostics & research" are considered alternatives and competitors to Genetic Signatures, including (BUX) (BUX), 12144 (IME), BARD1 Life Sciences (BD1), Charles River Laboratories International (CRL), Cryosite (CTE), and dorsaVi (DVL).

Genetic Signatures vs. (BUX) Stock

Genetic Signatures (ASX:GSS) and (BUX) (CNSX:BUX) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, valuation, institutional ownership, dividends and profitability.

Analyst Ratings

This is a breakdown of recent recommendations for Genetic Signatures and (BUX), as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Genetic Signatures	0	0	0	0	N/A
(BUX)	0	0	0	0	N/A

Profitability

This table compares Genetic Signatures and (BUX)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Genetic Signatures	N/A	N/A	N/A
(BUX)	N/A	N/A	N/A

Earnings & Valuation

This table compares Genetic Signatures and (BUX)'s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genetic Signatures	$29.13 million	0.00	$4.71 million	A$0.03	N/A
(BUX)	N/A	N/A	N/A	N/A	N/A

Genetic Signatures has higher revenue and earnings than (BUX).

Summary

Genetic Signatures beats (BUX) on 1 of the 1 factors compared between the two stocks.

Genetic Signatures vs. 12144 Stock

Genetic Signatures (ASX:GSS) and 12144 (CNSX:IME) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, valuation, institutional ownership, dividends and profitability.

Analyst Ratings

This is a breakdown of recent recommendations for Genetic Signatures and 12144, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Genetic Signatures	0	0	0	0	N/A
12144	0	0	0	0	N/A

Profitability

This table compares Genetic Signatures and 12144's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Genetic Signatures	N/A	N/A	N/A
12144	N/A	N/A	N/A

Earnings & Valuation

This table compares Genetic Signatures and 12144's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genetic Signatures	$29.13 million	0.00	C$4.71 million	A$0.03	N/A
12144	N/A	N/A	N/A	N/A	N/A

Genetic Signatures has higher revenue and earnings than 12144.

Summary

Genetic Signatures beats 12144 on 1 of the 1 factors compared between the two stocks.

Genetic Signatures vs. BARD1 Life Sciences Stock

Genetic Signatures (ASX:GSS) and BARD1 Life Sciences (ASX:BD1) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, valuation, institutional ownership, dividends and profitability.

Analyst Ratings

This is a breakdown of recent recommendations for Genetic Signatures and BARD1 Life Sciences, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Genetic Signatures	0	0	0	0	N/A
BARD1 Life Sciences	0	0	0	0	N/A

Profitability

This table compares Genetic Signatures and BARD1 Life Sciences' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Genetic Signatures	N/A	N/A	N/A
BARD1 Life Sciences	N/A	N/A	N/A

Earnings & Valuation

This table compares Genetic Signatures and BARD1 Life Sciences' top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genetic Signatures	$29.13 million	0.00	$4.71 million	A$0.03	N/A
BARD1 Life Sciences	$464,101.00	0.00	$-5,746,881.60	A($0.07)	N/A

Genetic Signatures has higher revenue and earnings than BARD1 Life Sciences.

Summary

Genetic Signatures beats BARD1 Life Sciences on 3 of the 3 factors compared between the two stocks.

Genetic Signatures vs. Charles River Laboratories International Stock

Genetic Signatures (ASX:GSS) and Charles River Laboratories International (CNSX:CRL) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, profitability, analyst recommendations and earnings.

Profitability

This table compares Genetic Signatures and Charles River Laboratories International's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Genetic Signatures	N/A	N/A	N/A
Charles River Laboratories International	N/A	N/A	N/A

Valuation and Earnings

This table compares Genetic Signatures and Charles River Laboratories International's top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genetic Signatures	$29.13 million	0.00	$4.71 million	A$0.03	N/A
Charles River Laboratories International	N/A	N/A	N/A	N/A	N/A

Genetic Signatures has higher revenue and earnings than Charles River Laboratories International.

Analyst Recommendations

This is a summary of current recommendations and price targets for Genetic Signatures and Charles River Laboratories International, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Genetic Signatures	0	0	0	0	N/A
Charles River Laboratories International	0	0	0	0	N/A

Summary

Genetic Signatures beats Charles River Laboratories International on 1 of the 1 factors compared between the two stocks.

Genetic Signatures vs. Cryosite Stock

Genetic Signatures (ASX:GSS) and Cryosite (ASX:CTE) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, profitability, analyst recommendations and earnings.

Profitability

This table compares Genetic Signatures and Cryosite's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Genetic Signatures	N/A	N/A	N/A
Cryosite	N/A	N/A	N/A

Valuation and Earnings

This table compares Genetic Signatures and Cryosite's top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genetic Signatures	$29.13 million	0.00	$4.71 million	A$0.03	N/A
Cryosite	$8.97 million	0.00	$1.41 million	A$0.03	N/A

Genetic Signatures has higher revenue and earnings than Cryosite.

Analyst Recommendations

This is a summary of current recommendations and price targets for Genetic Signatures and Cryosite, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Genetic Signatures	0	0	0	0	N/A
Cryosite	0	0	0	0	N/A

Summary

Genetic Signatures beats Cryosite on 3 of the 3 factors compared between the two stocks.

Genetic Signatures vs. dorsaVi Stock

dorsaVi (ASX:DVL) and Genetic Signatures (ASX:GSS) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk.

Analyst Ratings

This is a summary of current ratings and target prices for dorsaVi and Genetic Signatures, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
dorsaVi	0	0	0	0	N/A
Genetic Signatures	0	0	0	0	N/A

Profitability

This table compares dorsaVi and Genetic Signatures' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
dorsaVi	N/A	N/A	N/A
Genetic Signatures	N/A	N/A	N/A

Valuation & Earnings

This table compares dorsaVi and Genetic Signatures' gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
dorsaVi	$2.02 million	0.00	$-12,244,714.72	A($0.04)	N/A
Genetic Signatures	$29.13 million	0.00	$4.71 million	A$0.03	N/A

Genetic Signatures has higher revenue and earnings than dorsaVi.

Summary

Genetic Signatures beats dorsaVi on 3 of the 3 factors compared between the two stocks.